Introduction
============

Serotyping is a standard method for subtyping of *Escherichia coli* strains in taxonomical and epidemiological studies ([@B32]). In particular, the identification of strains of the same O serogroup is essential in outbreak investigations and surveillance for identifying the diffusion of a pathogenic clone ([@B12]; [@B27]; [@B39]; [@B17]). Thus far, the World Health Organization Collaborating Centre for Reference and Research on *Escherichia* and *Klebsiella*, which is based at the Statens Serum Institut (SSI) in Denmark^[1](#fn01){ref-type="fn"}^, has recognized 185 *E. coli* O serogroups. These are designated O1 to O188 (publication of O182 to O188 is pending) and include three pairs of subgroups, O18ab/ac, O28ab/ac, and O112ab/ac; and six missing numbers, O31, O47, O67, O72, O93, and O122 ([@B33]; [@B36]).

O-serogroup diversification shows a strong association with the genetic diversity of O-antigen biosynthesis genes. In *E. coli*, the genes required for O-antigen biosynthesis are clustered at a chromosomal locus flanked by the colanic acid biosynthesis gene cluster (*wca* genes) and the histidine biosynthesis (*his*) operon. Sequence comparisons of O-antigen biosynthesis gene clusters (O-AGCs) indicate a variety of genetic structures ([@B9]). In particular, sequences from O-antigen processing genes (*wzx*/*wzy* and *wzm*/*wzt*) located on the O-AGCs are highly variable and can be used as gene markers for the identification of O serogroups via molecular approaches. So far, several studies have reported genetic methodologies allowing rapid and low-cost O-typing of isolates ([@B7]; [@B3]; [@B5]; [@B41], [@B42]; [@B10]; [@B13]; [@B35]; [@B14]). In a previous study ([@B18]), we analyzed the O-AGC sequences of 184 known *E. coli* O serogroups (from O1 to O187), and organized 162 DNA-based O serogroups (O-genotypes) on the basis of the *wzx*/*wzy* and *wzm*/*wzt* sequences. Subsequently we presented a comprehensive molecular O-typing scheme: an *E. coli* O-genotyping polymerase chain reaction (ECOG-PCR) system using 20 multiplex PCR sets containing 162 O-genotype-specific PCR primers ([@B19]).

The Shiga toxin-producing *E. coli* (STEC) constitute one of the most important groups of food-borne pathogens, as they can cause gastroenteritis that may be complicated by hemorrhagic colitis or hemolytic-uremic syndrome (HUS; [@B38]). O157 is a leading STEC O serogroup associated with HUS ([@B39]; [@B17]) and other STEC O serogroups, including O26, O103, O111, O121 and O145, are also recognized as significant food-borne pathogens worldwide ([@B21]). Additionally, unexpected STEC O serogroups have sometimes emerged to cause sporadic cases or outbreaks. For example, STEC O104:H4 was responsible for a large food-borne disease outbreak in Europe in [@B4]. For such various O-serogroups, ECOG-PCR is an accurate and reliable approach for subtyping *E. coli* isolates from patients and contaminated foods ([@B19]; [@B31]). However, as our previous studies indicated, some of the tested strains were not classified into any of the known O genotypes, suggesting the presence of novel O genotypes ([@B19]).

Here, we analyzed the O-AGCs from genetically untypeable STEC strains (including strains from patients with diarrhea and hemorrhagic colitis) by the ECOG-PCR. By comparing sequences we revealed six novel O-genotypes and developed specific-PCRs for each novel O-genotype.

Materials and Methods {#s1}
=====================

O Serogrouping/O Genotyping
---------------------------

O serogroup were determined by agglutination tests in microtiter plates using commercially available pooled and single antisera against all recognized *E. coli* O antigens (O1 to O187; SSI Diagnostica, 156 Hillerød, Denmark). O genotypes were determined by ECOG-PCR as described in our previous study ([@B19]). *Salmonella enterica* O42 (SSI Diagnostica) and *Shigella boydii* type 13 (Denka Seiken Co. Ltd., Japan) single antisera were also used to test for the agglutination reaction.

Source Sequences of Novel O-Genotypes
-------------------------------------

The O-AGC sequences were determined from six O-genotype untypeable (OgUT) STEC strains, of which four were serologically typeable (O1, O39, O40, and O141) and two others were untypeable (OUT) strains (**Table [1](#T1){ref-type="table"}**). All strains were isolated from human feces (including patients with diarrhea and hemorrhagic colitis) in Japan from 2008 to 2012. The O-AGC sequences flanked by *wcaM* and *hisI* were extracted from draft genome sequences determined using an Illumina MiSeq sequencer (Illumina, San Diego, CA, USA), as previously described ([@B30]). Identification and functional annotation of the coding sequences were performed based on the results of homology searches against the public non-redundant protein database using BLASTP. Six O-AGC sequences reported in this paper have been deposited in the GenBank/EMBL/DDBJ database (accession no. LC125927-LC125932).

###### 

Shiga toxin-producing *E. coli* (STEC) strains used for sequencing of the O-AGC.

  Strain ID   Source (case*^a^*)   Year   O serogroup   O genotype   Novel O genotype   *stx1*   *stx2*   *eae*   Reference
  ----------- -------------------- ------ ------------- ------------ ------------------ -------- -------- ------- ---------------
  090823      Human (D)            2009   O1            OgUT         OgN10              \+       \-       \-      [@B19]
  100998      Human (BD)           2010   O39           OgUT         OgN31              \-       \+       \-      [@B19]
  121862      Human (D)            2012   O40           OgUT         OgN1               \-       \+       \-      [@B19]
  102755      Human (BD)           2010   O141          OgUT         OgN8               \-       \+       \-      [@B19]
  OT-11       Human (AC)           2008   OUT           OgUT         OgN9               \+       \-       \+      In this study
  EHO-67      Human (D)            2011   OUT           OgUT         OgN12              \+       \-       \-      In this study

a

AC, asymptomatic carrier; D, diarrhea; BD, bloody diarrhea.

Sequence Comparisons
--------------------

The *wzx*/*wzy* sequences from O-serogroup strains ([@B18]) and OX-groups reference strains ([@B8]) were used. Additionally, O-AGC sequences from O116 (AB812051; [@B18]), O1 (GU299791; [@B24]), O39 (AB811616; [@B18]), O141 (DQ868765; [@B16]), O40 (EU296417; [@B26]), *S. enterica* O42 (JX975340; [@B25]), and *S. boydii* type 13 (AY369140; [@B11]) were also used. Multiple alignments of DNA and amino acid sequences were constructed by using the CLUSTAL W program ([@B40]). Phylogenetic trees were constructed by using the neighbor-joining algorithm using MEGA5 software ([@B37]). Homology comparisons of paired sequences were performed by using the In Silico Molecular Cloning Genomics Edition (In Silico Biology, Inc., Yokohama, Japan).

PCR for Identifying Novel O-Genotypes
-------------------------------------

Polymerase chain reaction primers for specifically identifying novel O genotypes were designed (**Table [2](#T2){ref-type="table"}**) and their specificities were evaluated by using 185 O-serogroup reference strains (O1--O188) from SSI using the following PCR conditions. Genomic DNA from *E. coli* strains was purified using the Wizard Genomic DNA purification kit (Promega, Madison, WI, USA) or DNeasy Blood & Tissue Kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions. PCRs were performed using 10 ng/μl of template DNA. PCR was performed as follows: each 30-μl reaction mixture contained 2 μl of genomic DNA, 6 μl of 5× Kapa *Taq* buffer, dNTP mix (final concentration, 0.3 mM each), MgCl~2~ (final concentration, 2.5 mM), primers (final concentration, 0.5 μM each), and 0.8 U of Kapa *Taq* DNA polymerase (Kapa Biosystems, Woburn, MA, USA). The thermocycling conditions were: 25 cycles of 94°C for 30 s, 58°C for 30 s, and 72°C for 1 min. PCR products (2 μl) were electrophoresed in 1.5% agarose gels in 0.5× TBE (25 mM Tris borate, 0.5 mM EDTA), and photographed under UV light after the gel was stained with ethidium bromide (1 mg/ml).

###### 

Polymerase chain reaction (PCR) primer sequences for identification of six novel O genotypes.

  O genotype   Primer name   Target gene           Sequence (5′--3′)       Size (bp)
  ------------ ------------- --------------------- ----------------------- -----------
  OgN1         OgN1_PCR_F    *wzy*                 GGTTCCCTGTTGCCAATGGT    525
               OgN1_PCR_R                          GAGACGAACGTGCAGAAACCA   
  OgN8         OgN8_PCR_F    *wzy*                 AACCTTCGCTATGATGGGGG    940
               OgN8_PCR_R                          CTTTACCAGGGATGCTCCGA    
  OgN9         OgN9_PCR_F    *wzy*                 AAGGTTGGTAGCGTAGGGGA    423
               OgN9_PCR_R                          CTCGTATTTCGCCCCCATTC    
  OgN10        OgN10_PCR_F   *wzy*                 TGGTGCTGTGTGCTACCATTT   892
               OgN10_PCR_R                         AAAGCCAGCCTTAAATCGGA    
  OgN12        OgN12_PCR_F   *wzy*                 TTGTGGCACCTGATCCTGCT    223
               OgN12_PCR_R                         GCACATGCTAACCCTGCTCTT   
  OgN31        OgN31_PCR_F   Glycosyltransferase   GCCATAAAAAGAGCAAGGGGG   311
               OgN31_PCR_R                         GGGGCAGCTGAAAACCAATC    

Distributional Survey of Novel O-Genotypes
------------------------------------------

Thirty five O-serogrouped *E. coli* strains from our previous study ([@B19]), whose O genotypes were not identified by ECOG-PCR were used for screening novel O-genotypes by the PCR method designed in this study. The prevalence of *stx1*, *stx2* ([@B6]) and *eae* ([@B34]) genes in the tested STEC strains was determined by the PCR.

Results
=======

Novel O-Genotypes
-----------------

Six types of O-AGC were identified from OgUT STEC strains (**Figure [1](#F1){ref-type="fig"}**). Four O-AGCs (named OgN10, OgN31, OgN1, and OgN8 genotypes) were obtained from strains that were serologically classified into O1, O39, O40, and O141, respectively (**Table [1](#T1){ref-type="table"}**). Two others (named OgN9 and OgN12 genotypes) were obtained from strains that were both serologically and genetically unclassified into any groups (**Table [1](#T1){ref-type="table"}**). Actually, the OgN9 strain did not react with any particular antiserum, and OgN12 showed identical agglutination titers with O34 and O140 antisera, which resulted in OUT classsification. OgN8, OgN10, and OgN12 carried *rmlBDAC* for the synsthesis of deoxythymidine diphosphate (dTDP)-[L]{.smallcaps}-rhamnose, and OgN31 carried *rmlBA*-*vioA* for dTDP viosamine synthesis (**Figure [1](#F1){ref-type="fig"}**). OgN9 carried *fnlA-qnlBC* for UDP-*N*-acetyl-[L]{.smallcaps}-quinovosamine (UDP-[L]{.smallcaps}-QuiNAc) synthesis (**Figure [1](#F1){ref-type="fig"}**). All novel O-AGCs carried the *wzx/wzy* O-antigen processing genes (**Figure [1](#F1){ref-type="fig"}**). The *wzx/wzy* sequences from OgN O-AGCs were compared with those from 171 O-serogroup strains and 11 OX-group reference strains, indicating that their sequences were unique compared to those from known O-AGCs (less than 70% DNA sequence identity of closest pairs), except for *wzx* of OgN31 (**Figure [2](#F2){ref-type="fig"}**). The sequence of OgN31\_*wzx* was 98.7% identical in DNA sequence (99.0% amino acid sequence identity) to that of O116. Sequence comparison of O-AGCs revealed that the left region including *wzx* and genes for the d-TDP glucose pathway was conserved between OgN31 and Og116, and the right region including the *wzy* and glycosyltransferase genes was unique (less than 40% DNA sequence identity) in each O-AGC (**Figure [3A](#F3){ref-type="fig"}**). O-AGC gene sets from four pairs with members of different genotypes that agglutinated with the same O antisera were compared (**Figure [3B](#F3){ref-type="fig"}**). Between OgN10 and Og1 (from O1 strain), and between OgN8 and Og141 (from O141 strain), *rmlBDAC* genes were highly conserved in both O-AGCs, while other genes including *wzx* and *wzy* were diversified (less than 70% DNA sequence identity). Between OgN31 and Og39 (from O39 strain), different types of sugar biosynthesis genes were located on each O-AGC (*rmlBA*-*vioA* on OgN31, and *rmlBDAC-vioAB* and *manCB* on Og39). There was no genetic similarity between OgN1 and Og40 (from O40 strain). From these results, we were convinced that these six were novel O-AGCs.

![**Six novel O-AGCs from STEC strains.** The O-AGCs flanked by *wcaM* and *hisI* were extracted from draft genome sequences.](fmicb-07-00765-g001){#F1}

![**Phylogenetic analysis of Wzx and Wzy homologs from six novel O-AGCs, *Escherichia coli* O-serogroup strains and OX-groups reference strains based on the amino acid sequences (except for *wzy* of OX25, which is not found in the O-AGC of OX25).** Pairs or groups of homologs with ≥95% DNA sequence identity are indicated in red, and ≥70% identity is indicated in blue. Other homologs with low sequence homologies (less than 70%) are indicated in black.](fmicb-07-00765-g002){#F2}

![**Comparison of O-AGCs. (A)** The pair of O-AGCs, OgN31 and O116. **(B)** Four pairs that were serologically agglutinated with the same O antisera carried different types of O-AGCs. Lower genes show the O-AGCs from O-serogroup strains. **(C)** Similar O-AGCs in strains of other genera. Amino acid sequence identities (%) between homologs are shown in the middle.](fmicb-07-00765-g003){#F3}

A BLAST search of the NCBI database revealed that the OgN10 O-AGC is similar to that of *S. enterica* O42, and the OgN9 O-AGC was almost identical to that of *S. boydii* type 13 (**Figure [3C](#F3){ref-type="fig"}**). OgN10 and OgN9 strains agglutinated with *S. enterica* O42 and *S. boydii* type 13 antisera, respectively (data not shown).

Primers for Identifying Novel O Genotypes
-----------------------------------------

Six PCR primer pairs were designed for identifying the novel O-genotypes (**Table [2](#T2){ref-type="table"}** and **Figure [4](#F4){ref-type="fig"}**). All primer pairs were targeted unique sequences of *wzy*, except for OgN31 for which primers were targeted to a glycosyltransferase gene. Each PCR was evaluated by using all 185 O-serogroup reference strains from O1 to O188 and six novel O-genotype strains (listed in **Table [1](#T1){ref-type="table"}**). PCR products of the expected sizes on the agarose gel were obtained only with the corresponding strains, and no extra products were observed in the size range between 100 and 1,500 bp (data not shown).

![**Polymerase chain reaction (PCR) products of OgN strains by each specific-primer pair.** (1) OgN1 (525 bp), (2) OgN8 (940 bp), (3) OgN9 (423 bp), (4) OgN10 (892 bp), (5) OgN12 (232 bp), (6) OgN31 (311 bp), M; 100-bp DNA ladder markers.](fmicb-07-00765-g004){#F4}

Distribution of Novel O-Genotypes
---------------------------------

Among 35 O-serogrouped *E. coli* strains whose O genotypes were not identified by the ECOG-PCR, five O141, three O1, three O39, one O40, and one O140 strains were classified by using the novel O-genotype PCR into OgN8, OgN10, OgN31, OgN1, and OgN12, respectively (**Table [3](#T3){ref-type="table"}**). All 13 strains classified into five novel O-genotypes were *eae*-negative STEC, and OgN8, OgN10, and OgN31 had been isolated from patients with bloody diarrhea. OgN8 and OgN12 strains also cross-reacted with O41 and O34 antisera, respectively.

###### 

List of STEC strains classified into novel O genotypes by PCR screening.

  Strain ID   Source (case*^a^*)   Year   O serogroup   O-genotype   Novel O genotype*^b^*   *stx1*   *stx2*   *eae*
  ----------- -------------------- ------ ------------- ------------ ----------------------- -------- -------- -------
  121862      Human (D)            2012   O40           OgUT         OgN1^∗^                 \-       \+       \-
  102755      Human (BD)           2010   O141          OgUT         OgN8^∗^                 \-       \+       \-
  110906      Human (AC)           2011   O141          OgUT         OgN8                    \-       \+       \-
  133345      Human (AC)           2013   O141          OgUT         OgN8                    \+       \+       \-
  PV10-60     Food                 2010   O141          OgUT         OgN8                    \-       \+       \-
  PV12-70     Food                 2012   O141          OgUT         OgN8                    \-       \+       \-
  072583      Human (BD)           2007   O1            OgUT         OgN10                   \-       \+       \-
  090823      Human (D)            2009   O1            OgUT         OgN10^∗^                \+       \-       \-
  091971      Human (AC)           2009   O1            OgUT         OgN10                   \+       \-       \-
  091275      Human (AC)           2009   O140          OgUT         OgN12                   \+       \-       \-
  100998      Human (BD)           2010   O39           OgUT         OgN31^∗^                \-       \+       \-
  100999      Human (D)            2010   O39           OgUT         OgN31                   \-       \+       \-
  NBK\#585    Human (AC)           --     O39           OgUT         OgN31                   \-       \+       \-

a

AC, asymptomatic carrier; D, diarrhea; BD, bloody diarrhea.

b

Strains used for sequencing of the O-AGC are indicated by asterisks. All strains were isolated in Japan.

Discussion
==========

In this study, six novel O genotypes were revealed from STEC strains isolated from human patients, and the prevalence of these O genotype strains was confirmed in STECs. The OgN10 strains were serologically classified into the O1 serogroup. The O1-serogroup strain is often seen in extra-intestinal pathogenic *E. coli* from patients with urinary tract infections ([@B1]; [@B29]) and septicemic disease ([@B29]), and in avian pathogenic *E. coli* ([@B29]; [@B23]). Our previous study showed that an O1 strain isolated from patient blood was classified into Og1 ([@B19]) and sequence comparisons showed that both an APEC O1 strain from avian colibacillosis ([@B22]) and the G1632 strain from a patient with a urinary tract infection ([@B24]) carried the Og1-type O-AGC, whereas three STEC O1 strains used in this study were all classified into OgN10. Actually, we confirmed that five STEC O1 strains from cattle used in a previous study, described as O1B type ([@B28]) were also classified into OgN10 (data not shown). In fact, *E. coli* O1 strains could be generally subtyped into two genotypes, Og1 and OgN10, which were clearly linked to extra-intestinal/avian pathogenic *E. coli* and STEC, respectively. Among the O1 serogroup, three types of antigen structures have so far been reported ([@B2]; [@B15]) and the β-linked side-chain *N*-acetyl-[D]{.smallcaps}-mannosamine residue was suggested to be a common O1-specific epitope ([@B15]). A partial kinship of O antigen structure synthesized from different O-AGCs may be serologically recognized as the same O serogroup and may also be represented in OgN1 OgN8, OgN12, and OgN31 strains, related to O40, O141, O140, and O39, respectively. The subdivision within each O-serogroup based on the O-AGC DNA sequences may be useful for obtaining more reliable information for epidemiological studies of pathogenic *E. coli*. Another advantage for DNA-based typing is that serologically untypeable and ambiguous strains could be clearly classified. At the present time, the PCR-based method reported here is the only way to distinguish OgN9. Although, STEC OgN groups have not emerged as a major public health issue, these groups are believed to be a possible cause of diarrhea and bloody diarrhea. To gain more information about trends in STEC OgNs epidemiology, further studies of global OgN isolates are needed. The PCR method described in this study may help the surveillance and monitoring of the OgN groups. Additionally, published sequences from OgN O-AGCs may be used for other DNA-based methodologies, such as *in silico* typing using whole genome sequencing data ([@B20]).
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